Dublin, July 20, 2017 -- The "RNAi Technology - 2017: Insect and Pest Control, Disease and Weed Control, Crop Enhancement, Formulation and Delivery, Patents, Safety and Regulations, Company Profiles, Specialist Institutes" report has been added to Research and Markets' offering.
Employed as a research tool in entomology and as a means of crop protection and pest control, RNA interference (RNAi) technology is a natural process used to silence' genes - a way of reducing or switching off the activity (or expression) of individual genes.
With a major drive to tackle resistance to insecticides, RNAi technology has important defence and regulatory functions in animals, plants and fungi. Producing crop hybrids and varieties with enhanced yield and quality characteristics is also a major application of this technology, and superior traits brought to market include improved oil composition (high oleic acid), reduced lignin content (for greater digestibility of feed by livestock), the elimination of browning when slicing apples and potatoes, and reduced potential for acrylamide production when frying potatoes.
This report provides an overview of RNAi technology and its use in new product development for improved crop varieties, crop protection and pest control. It details company and product profiles, and activities and pipelines of specialist companies and research institutes engaged in RNAi technology. It also reviews key safety considerations for the technology, as well as commentary and positions of European and US regulatory authorities.
Other focus areas of this report include research undertaken and commentary about future sprayable RNAi technology, patent applications claiming the use of the technology for disease control, and newer commercial drivers for RNAi applications in crop protection as a possibility of overcoming herbicide resistance in weeds. Increasing crop production in responses to abiotic stress (such as drought) is also considered.
Key Topics Covered:
Executive Summary
1. Introduction
1.1 Summary
1.2 Introduction
1.3 Scope
1.4 Technical background
1.4.1 History
1.4.2 Science of RNAi
1.4.2.1 The flow of information in the cell: from DNA to protein via mRNA
1.4.2.2 Discovery of RNA interference
1.4.2.3 Role of RNAi in nature
1.4.2.4 The RNAi process and machinery
1.5 Safety and regulations
1.5.1 Safety
1.5.1.1 Environment
1.5.1.2 Food and feed
1.5.1.3 Non-target organisms
1.5.2 Regulations
1.5.2.1 Europe
1.5.2.2 USA
1.6 References and resources
2. RNAi for controlling insects and other pests
2.1 Summary
2.2 Introduction
2.2.1 Role of RNAi technology
2.2.2 Progress in using RNAi technology
2.3 Coleoptera
2.4 Lepidoptera
2.5 Diptera
2.6 Hemiptera
2.7 Nematodes
2.8 Other pests
2.8.1 Fire ants
2.8.2 Spider mites
2.8.3 Mites
2.8.4 Locusts
2.8.5 Termites
2.9 Patent applications
2.9.1 Insects
2.9.2 Nematodes
2.10 References and resources
3. RNAi in other crop sectors
3.1 Summary
3.2 Introduction
3.3 Control of diseases
3.3.1 Viruses
3.3.2 Progress with RNAi for disease control
3.3.3 Disease control patent applications
3.4 Control of weeds
3.4.1 Overcoming herbicide resistance
3.4.2 Control of parasitic weeds by RNAi
3.5 Crop enhancement
3.5.1 Modified oil composition
3.5.2 Reduced lignin
3.5.3 Abiotic stress
3.5.4 Enzymatic browning
3.5.5 Crop Enhancement patent applications
3.6 References and resources
4. Formulation and delivery of RNAi
4.1 Summary
4.2 Introduction
4.3 Principles
4.3.1 Knowledge base from human therapeutics
4.3.2 Progress in crop protection and pest control
4.3.3 Collaborations
4.4 Patent activity
4.5 References and resources
5. Crop protection companies
5.1 Summary
5.2 Introduction
5.3 BASF
5.3.1 Modified starch potatoes
5.3.2 Disease control
5.3.3 Nematode control
5.3.4 Weed control
5.4 Bayer CropScience
5.4.1 Collaborations
5.4.2 Patent applications
5.5 Dow AgroSciences
5.6 DuPont
5.7 Monsanto
5.7.1 Low lignin alfalfa
5.7.2 SmartStax Pro (MON87411)
5.7.3 BioDirect
5.7.4 Rosetta Green acquisition
5.7.5 Preceres and RNAi delivery R&D
5.7.6 Patent applications
5.8 Syngenta
5.8.1 Collaborations
5.8.2 Patent applications
5.9 References and resources
6. Specialist RNAi technology companies and institutes
6.1 Summary
6.2 Introduction
6.3 Alnylam Pharmaceuticals
6.4 Arbutus Biopharma
6.5 CSIRO
6.6 Evogene
6.7 Forage Genetics
6.8 Forrest Innovations
6.9 Fraunhofer Institute for Molecular Biology and Applied Ecology
6.10 Ghent University
6.11 Iden Biotechnology
6.12 Intrexon
6.13 J. R. Simplot
6.14 Okanagan Specialty Fruits
6.15 Nemgenix
6.16 Performance Plants
6.17 PhaseRx
6.18 Preceres
6.19 University of Cambridge
6.20 University of Nebraska
6.21 Tekmira
6.22 Venganza
6.23 References and resources
For more information about this report visit https://www.researchandmarkets.com/research/mwvrrr/rnai_technology
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Crop Farming


Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
First Western Ship Transits Strait of Hormuz Since Iran War Began
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
UPS and Teamsters Reach Agreement to Limit Driver Severance Program
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
Britain Courts Anthropic Amid US Defense Department Dispute 



